In the first part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, explains how ...
Competition for biotech and pharma employment picked up year over year and remains strong, according to BioSpace data. A survey late last year showed that 64% of employed/contract and 96% of ...
As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's competitive position.
Investing.com on MSN
Amneal Pharmaceuticals' SWOT analysis: generic drug maker's stock poised for growth
Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...
On Thursday, Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, but missing the consensus of 94 cents. Amphastar is a ...
Industry reports the Saudi pharmaceutical CDMO market is expected to increase from USD $1.62 billion in 2024 to USD $2.24 billion by 2030 at a compound annual growth rate (CAGR) of 5.45%, reflecting ...
Oncoscope launches the first Real-time, AI-supported Living Systematic Literature Review designed for enterprise-wide ...
DelveInsight provides structured pharma conference coverage solutions designed to help industry leaders to track and interpret critical developments emerging from major healthcare conferences.
Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...
Explore key identity management challenges in pharma and biotech SaaS platforms and learn practical solutions for security, compliance, and scalability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results